Rare pathogenic variants in cancer predisposition genes increase the risk of developing single and multiple primary cancers, researchers found.

Additionally, the agency is eliminating the 'adequate provision' loophole that allowed pharmaceutical companies to list complete risks separately.

(HealthDay News) — The percentage of U.S. adults using nicotine pouches remains low, according to a research letter published online Sept. 8 in JAMA Network Open.

Lowest representation seen for studies on arrhythmia, coronary heart disease, acute coronary syndrome, and heart failure.

Early prediction and prevention of venous thromboembolism is crucial in high-risk populations, such as hospitalized patients with bladder cancer.

Artificial neural networks based on these biomarkers demonstrated strong predictive ability for AAV risk, validated across multiple data sets and patient renal biopsy samples.

The FDA has approved Enbumyst, a nasal spray formulation of bumetanide, for the treatment of edema associated CHF, and hepatic and renal disease.

Prostate involvement was first reported in IgG4-RD approximately 2 decades ago and comprises only 9.6% of cases.

(HealthDay News) — Consuming high levels of ultraprocessed foods is associated with increased levels of high-sensitivity C-reactive protein (hsCRP), according to a study published online Sept. 3 in ...

Anemia along with renal tubular damage (RTD) is associated with all-cause mortality in the general population, suggesting it’s a novel risk factor that could enhance prognostic ...

Study investigators evaluated patient and tumor characteristics to identify potential risk factors for first-year recurrence after cytoreductive nephrectomy for mRCC.

NCD mortality declined in all high-income Western countries, with largest decline for both sexes in Denmark and smallest in U.S.